Claim Missing Document
Check
Articles

Found 21 Documents
Search

Perkembangan Terapi Sel Punca (Stem Cell) Pada Penyakit Jantung: Masa Kini dan Masa Depan Idrus Alwi
Medica Hospitalia : Journal of Clinical Medicine Vol. 1 No. 2 (2012): Med Hosp
Publisher : RSUP Dr. Kariadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (958.197 KB) | DOI: 10.36408/mhjcm.v1i2.47

Abstract

Penelitian terapi sel punca di dunia telah berkembang dengan pesat dalam beberapa dasa warsa terakhir, khususnya pada penyakit jantung seperti infark miokard akut, penyakit jantung koroner tahap akhir (PJTA) dan kardiomiopati. Di masa mendatang terapi sel punca dianggap sebagai batas akhir (final frontier) pengobatan berbagai penyakit. Oleh karena itu pengembangan terapi sel punca diharapkan dapat menjawab berbagai tantangan dalam tatalaksana berbagai penyakit secara mendasar. Indonesia merupakan salah satu pelopor terapi sel punca pada infark miokard akut di Asia Tenggara dan merupakan salah satu negara pertama di Asia selain Hongkong yang menggunakan alat NOGA untuk pemetaan (mapping) dan injeksi sel punca pada otot jantung melalui kateterisasi pada PJTA. Sel punca termasuk embryonic stem cells (ESC), cardiac stem cells (CSCs) dan induced pluripotent stem cells (iPSs) dapat mengalami diferensiasi menjadi kardiomiosit dan dapat mengembalikan fungsi kontraksi jantung. Sel tersebut juga dapat berdiferensiasi menjadi sel endotel, memicu pembentukan pembuluh darah baru (angiogenesis), mengembalikan sebagian sel otot jantung yang rusak menjadi tetap hidup, dan menghambat perluasan jaringan parut. Mekanisme lain terapi sel punca pada jantung yang saat ini banyak dianut adalah melalui efek parakrin. Terdapat beberapa metoda pemberian sel punca pada jantung yaitu intrakoroner, epikardial dan intravena. Penelitian di bidang kedokteran kardiovaskular regeneratif mengenai terapi sel punca akan terus berkembang di masa depan, termasuk mengenai jenis sel dan teknik terbaik pemberian sel punca.
Correlation between Serum Uric Acid Level and Severity of Coronary Artery Stenosis in Patients with Acute Coronary Syndrome Diding Heri Prasetyo; Sally Aman Nasution; Idrus Alwi; Murdani Abdullah
Majalah Kedokteran Bandung Vol 53, No 1 (2021)
Publisher : Faculty of Medicine, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15395/mkb.v53n1.2221

Abstract

Acute coronary syndrome (ACS) is a life-threatening disease which remains one of the causes of high morbidity and mortality despite the current advances in treatment. The relationship between the serum uric acid  (SUA) level and ischemic heart disease continues to be controversial and still has not been established as a cardiovascular risk factor. The cooperative interaction between the two factors has not yet fully understood. Prior epidemiological evidence of the causal relationship between the too is still argumentative. Various studies have been done using the same methods; yet, the outcomes were different. This study aimeds to conduct a meta-analysis to synthesize the results of recent studies in order to obtain accurate quantitative data. This systematic study followed the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guideline and studies published in the period of  January 2010 to May 2020 were screened using the Cochrane Library, Ebsco, Medline/PubMed, ProQuest and Science Direct as the sources. Meta-analysis was conducted to synthesize the association between the SUA level and severity of coronary artery stenosis using random effect model to account for possible study heterogeneity. Heterogeneity was assessed using I2 and the meta-analysis was performed using Comprehensive Meta Analysis Version 3 (CMA3) software. Five studies (n = 601 subjects) identified a correlation between serum uric acid level and Gensini score (r = 0.548; p <0.001) in ACS patients. Heterogeneity bias was found in the analysis, whereas publication bias was not found. Thus, the severity of coronary artery stenosis in patients with ACS is positively correlated with serum uric acid level.
Kesahihan dan Keandalan Uji Jalan Enam Menit pada Lintasan 15 Meter Nury Nusdwinuringtyas; Idrus Alwi; Faisal Yunus
Media Penelitian dan Pengembangan Kesehatan Vol 28 No 2 (2018)
Publisher : Sekretariat Badan Penelitian dan Pengembangan Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/mpk.v28i2.178

Abstract

Walk test is a test that often used because walking is a basic activity. There are time-based walk tests and some are based on track length. A 6-minute walk test is a time-based walk test with a distance trevaled as a result. A 6-minute walk test is frequently used as functional clinical capacity trial. This test is performed on a straight track. The length of the track varies from 10-meters to 85-meters. This study examined the reliability and validity of a 6-minute walk test on a 15-meter track. The 15-meter track with markers every 3-meters, 30-centimeters wide to the right and left from the center line. The subject went straight as close to the center line as possible. When the subject arrived at both ends, the subject rotated with the three step method. The study compared the 6-minute walk test on the 15-meter track with three-step rotating method with on Biodex® gait trainer gold-standard. This study involved subjects as many as 123 healthy Indonesians adults (58 men, 65 women), and obtained Cronbach alpha of 0.999 and Pearson correlation value of 0.998. This shows that the results of the 15-meter trajectory test have validity and precision values which are as good as the 6-minute walk test without spinning. Abstark Uji jalan merupakan uji yang sering dipakai karena berjalan merupakan aktivitas dasar. Uji jalan ada yang berbasis waktu dan berbasis panjang lintasan. Uji jalan enam menit merupakan uji berbasis waktu dengan jarak tempuh sebagai hasil keluarannya. Uji jalan 6 menit merupakan uji klinis kapasitas fungsional yang sering dipergunakan. Uji ini dilakukan pada lintasan lurus. Panjang lintasan bervariasi dari 10 meter hingga 60 meter.. Penelitian ini meneliti keterandalan dan kesahihan uji jalan enam menit pada lintasan 15 meter. Lintasan sepanjang 15 meter dengan marka setiap tiga meter, lebar lintasan 30 sentimeter ke kanan dan ke kiri dari garis tengah. Subyek berjalan lurus sedekat mungkin dengan garis tengah lintasan. Ketika subyek tiba pada ke dua ujung , berbalik arah dengan metoda tiga langkah. Penelitian ini membandingkan uji jalan 6 menit pada lintasan 15 meter dengan metoda berputar pada ke dua ujungnya dengan baku emas uji jalan 6 menit pada Biodex®gait trainer. Melibatkan subyek 123 orang Indonesia dewasa sehat (58 laki-laki), didapatkan Cronbach alfa 0,999 dengan nilai korelasi r= 0,998. Hal ini memiliki arti bahwa hasil lintasan 15 meter memiliki kesahihan dan nilai ketepatan yang sama baiknya dengan uji jalan 6 menit.
Curcumin’s Antioxidant Properties in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial Todung Silalahi; Idrus Alwi; Frans Suyatna; Katarina Dewi Sartika; Christopher Surya Suwita
The Indonesian Biomedical Journal Vol 14, No 1 (2022)
Publisher : The Prodia Education and Research Institute (PERI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18585/inabj.v14i1.1734

Abstract

BACKGROUND: Percutaneous coronary intervention (PCI) is the most common intervention for coronary artery disease (CAD) with very low complications. High oxidative stress post-PCI is associated with further atherosclerosis progression. Curcumin, extracted from a specific type of herbs, exhibits anti-oxidant properties by acting as hydrogen and electron donor for superoxide radicals. The aim of this study is to determine the effect of curcumin’s antioxidant properties in reducing oxidative stress of post-PCI in stable CAD.METHODS: This study was a double-blind parallel randomized controlled trial among 50 stable CAD patients undergoing PCI in Cipto Mangunkusumo General Hospital and Jakarta Heart Center. The subjects received either 45 mg/day curcumin or placebo 7 days pre-PCI until 48 hours post-PCI. Reduced oxidative stress markers (decreased MDA or increased GSH) were measured in 3 phases (7 days pre-PCI, 24 hours post-PCI, 48 hours post-PCI).RESULTS: Curcumin group showed increased MDA from baseline to 24 hours (Δ1=0.01 vs. 0.03; p=0.3) and decreased MDA from baseline to 48 hours (Δ2=-0.06 vs. 0.03; p=0.9). While, curcumin group showed decreased GSH from baseline to 24 hours (Δ1=-49.7% vs. 12.2%; p=0.4) and from baseline to 48 hours (Δ2=-19.09% vs. 11.4%; p=0.6). However, no significant changes were found in malondialdehide (MDA) and glutathione (GSH) level after the intervention.CONCLUSION: The 45 mg/day curcumin supplementation from 7 days pre-PCI until 48 hours post-PCI had no significant antioxidant effect in stable CAD post-PCI.KEYWORDS: coronary artery disease, curcumin, antioxidant, percutaneous coronary intervention
Comparison of Light Transmission Aggregometry and VerifyNow in Detecting Clopidogrel Resistance and Factors Affecting Clopidogrel Resistance in AMI-EST Patients Undergoing Percutaneous Coronary Intervention: A Cross-Sectional Study Astuti Giantini; Ina Susianti Timan; Erlin Listiyaningsih; Rahajuningsih Dharma; Rianto Setiabudy; Idrus Alwi; Lia Gardenia Partakusuma; Nuri Dyah Indrasari; Alida Roswita Harahap; Siskawati Suparmin; Windy Sahar; Renan Sukmawan
The Indonesian Biomedical Journal Vol 13, No 2 (2021)
Publisher : The Prodia Education and Research Institute (PERI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18585/inabj.v13i2.1477

Abstract

BACKGROUND: Light transmission aggregometry (LTA) and VerifyNow is commonly used to measure platelet responsiveness to clopidogrel. This study aimed to compare the results of LTA and VerifyNow P2Y12 assay for assessing the clopidogrel resistance in patients undergoing percutaneous coronary intervention and determine factors affecting clopidogrel resistance.METHODS: The subjects were 119 patients who underwent percutaneous coronary intervention (PCI) and had given loading dose of 600 mg clopidogrel. Blood samples were taken at 6 hour after clopidogrel loading dose. Platelet aggregation was measured by LTA and VerifyNow.RESULTS: LTA and VerifyNow assay showed fair agreement with Kappa=0.270, p=0.001. The proportion of resistance to clopidogrel using VerifyNow was 21.8% and LTA was 47.1%. Patients with diabetes melitus were more likely to develop clopidogrel resistance than patients without diabetes (OR of 7.67; 95% CI: 1.87-31.50; p=0.005).CONCLUSION: The ability of LTA and VerifyNow in detecting clopidogrel resistance were not comparable. Multivariate analysis results for VerifyNow shows diabetes mellitus as the greatest predictors of clopidogrel resistance.KEYWORDS: agreement, clopidogrel resistance, LTA, predictor, VerifyNow 
Hyaluronic Acid Accelerates VEGF and PDGF Release from Advance Platelet Rich Fibrin in Diabetic Foot Ulcer Ronald Winardi Kartika; Idrus Alwi; Franciscus Dhyanagiri Suyatna; Ferry Sandra; Em Yunir; Sarwono Waspadji; Suzzana Immanuel; Todung Silalahi; Saleha Sungkar; Jusuf Rachmat; Saptawati Bardosono; Mirta Hediyati Reksodiputro
The Indonesian Biomedical Journal Vol 13, No 3 (2021)
Publisher : The Prodia Education and Research Institute (PERI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18585/inabj.v13i3.1523

Abstract

BACKGROUND: Hyaluronic acid (HA) is an essential component of extracellular matrix and mediates signaling in wound healing. HA could induce growth factor release from Advanced Platelet Rich Fibrin (A-PRF), including Vascular Endothelial Growth Factor (VEGF) and Platelet-derived Growth Factor (PDGF). However, concentrations of the released-VEGF and PDGF have not been clearly disclosed. Therefore, current study was conducted to measure the release of these growth factors in HA + A-PRF gel of diabetic foot ulcer (DFU) subjects.METHODS: Twenty DFU subjects were included in the study and treated with A-PRF or HA+A-PRF. A-PRF was derived from autologous peripheral blood and processed with low-speed centrifugation. HA was added with a ratio of 1:0.6. A-PRF or HA + A-PRF was applied topically on DFU. Upper tips of A-PRF or HA + A-PRF gels were collected on day 0, 3 and 7 for measurements of VEGF and PDGF concentrations with Enzyme-linked Immune-sorbent Assay (ELISA) methods.RESULTS: On day-3, both VEGF and PDGF concentrations of HA + A-PRF group were significantly higher than the VEGF (p=0.000) and PDGF (p=0.019) concentrations of A-PRF group. The VEGF and PDGF concentrations were continuously and significantly increased on day-7 of HA + A-PRF group, compared to the VEGF (p=0.000) and PDGF (p=0.004) concentrations of A-PRF group.CONCLUSION: Combination HA+A-PRF induces VEGF and PDGF release from A-PRF. A mixture of A-PRF and HA could be more effective than A-PRF alone for treatment of DFU.KEYWORDS: hyaluronic acid, advanced platelet rich fibrin, PRF, growth factor, VEGF, PDGF, diabetic foot ulcer
Advance-Platelet Rich Fibrin and Hyaluronic Acid Combination Improves Interleukin-6 and Granulation Index in Diabetic Foot Ulcer Patients Ronald Winardi Kartika; Idrus Alwi; Franciscus Dhyanagiri Suyatna; Em Yunir; Sarwono Waspadji; Suzanna Immanuel; Todung Silalahi; Saleha Sungkar; Jusuf Rachmat; Saptawati Bardosono; Mirta Hediyati Reksodiputro
The Indonesian Biomedical Journal Vol 13, No 2 (2021)
Publisher : The Prodia Education and Research Institute (PERI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18585/inabj.v13i2.1501

Abstract

BACKGROUND: Diabetic foot ulcer (DFU) is the most common and threatening complication of Diabetes Mellitus (DM). Ideal wound dressing for DFU management should relieve symptoms, provide wound protection, and encourage healing. Advanced-Platelet Rich Fibrin (A-PRF) and Hyaluronic Acid (HA) have been proven to improve wound healing process. This study was aimed to demonstrate the ability of combination of A-PRF and HA in reducing inflammation and improving DFU tissue healing.METHODS: Twenty DFU subjects were involved in this study, and divided into two groups based on the topical fibrin gel treatment: A-PRF + HA group and A-PRF only group. A-PRF was obtained by peripheral blood centrifugation. A-PRF + HA was prepared by homogening A-PRF and AH with a ratio of 1:0.6. Interleukin-6 (IL-6) level, granulation index (GI), numeric pain score (NPS), and inflammation clinical symptoms (ICS) were assessed on day-0, 3, 7 and 14.RESULTS: Wound swabs’ IL-6 level on day-7 was found to be significantly lower in A-PRF + HA compared to A-PRF alone (p=0.041). The IL-6 level reduction also found to be significant higher either in wound swabs (day 0-7, p=0.015) or fibrin gel (day 0-3, p=0.049; day 0-7, p=0.034). A-PRF + HA treatment significantly increased the GI even since day-3 (p=0.043), with lower NPS (p<0.001), and ICS score.CONCLUSION: The combination of A-PRF and HA increases the GI in DFU healing by reducing the inflammation state which will induce the angiogenesis process, as well as reducing pain in DFU subjects better than A-PRF alone.KEYWORDS: inflammation, interleukin-6, wound healing, angiogenesis, proliferation 
PENGARUH JUMLAH ALTERNATIF JAWABAN TES OBYEKTIF BENTUK PILIHAN GANDA TERHADAP RELIABILITAS,TINGKAT KESUKARAN DAN DAYA PEMBEDA Idrus Alwi
Faktor Exacta Vol 3, No 2 (2010): Faktor Exacta
Publisher : LPPM

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (265.792 KB) | DOI: 10.30998/faktorexacta.v3i2.19

Abstract

The purpose of this research was to examine the effect of the alternative numbers in a multiple choice test on reliability, level of difficulty and discriminatory power. The random technique was implemented to take the sample which consisted of the third year students of MTs N 7 Jakarta. The sample was 150 student. The data were collected through achievement test of mathematics. The one way analisys of variance was used to analyze the data. The result indicated that : (1) the alternative number in a multiple choice test had a significant effect on reliability of the test, (2) The alternative number in a multiple choice test had no significant effect on the level of difficulty, (3) but the alternative number in a multiple choice test had a significant effect on the discriminatory power. Keywords: alternative numbers, multiple choice, reliability
Prolonged QTc-Interval in Liver Cirrhotic Patient: Prevalence and Its Relationship with Severity of Liver Dysfunction Iman Firmansyah; Irsan Hasan; Laurentius Lesmana; Idrus Alwi; Pudji Rahardjo
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy VOLUME 5, ISSUE 1, April 2004
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/5120041-6

Abstract

Background: The aim of the study was to determine the prevalence of prolonged QTc -interval and it’s relationship with the severity of liver dysfunction in liver cirrhotic patient in the outpatient clinic of Hepatology, Dr. Cipto Mangunkusumo General National Hospital Methods: cross sectional study. Eighty one subjects was recruited and being followed as a consecutive non random sampling. The patient was divided according to the modified Child-Pugh classification and undergo to the ECG examination (with minimal 2 leads have measured QT-interval; one of these is II, aVL, V2 or V3 lead). Result: The prolonged QTc-interval prevalence in liver cirrhotic patient was found in 55 subjects (67,9%) with the mean 448.6 msec (SD = 28,9; 95% CI = 442.2 - 454.8). Using the Forward Stepwise Method in multivariate analysis to the independent variables (p 0.05) was found only the modified Child-Pugh classification had strongly correlation with the prolonged QTc-interval (OR = 11.2; 95% CI = 3.57-35.47; p = 0.000) Conclusion: The prolonged QTc-interval prevalence in liver cirrhotic patient is 67.9%. The prolonged QTc-interval were strongly associated with the severity of liver dysfunction. Keywords: The prolonged QTc-interval, liver dysfunction, liver cirrhosis
Left Ventricular Diastolic Dysfunction in Liver Cirrhotic Patients: Proportion, Correlation, and Relationship of Diastolic Parameters with Stage of Liver Dysfunction Mondrowinduro, Prionggo; Hasan, Irsan; Alwi, Idrus; Abdullah, Murdani
Jurnal Penyakit Dalam Indonesia Vol. 5, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Introduction. Cardiovascular complication of liver cirrhosis is relatively obscure. Pathophysiology of liver cirrhosis, involving portal hypertension made the possibility of cirrhosis complication manifested as left ventricular diastolic dysfunction. This study aims to determine proportion of left ventricular diastolic dysfunction among liver cirrhotic patients according to American Society of Echocardiography-European Association of Echocardiography (ASE-EAE) 2009 and conventional approach, to determine any correlation between left ventricular diastolic dysfunction severity stages with severity stages of liver dysfunction in cirrhotic patients represented by Child Turcotte Pugh (CTP ) score, also to asses relationship between severity stages of parameters of diastolic function according to ASE-EAE 2009 with liver cirrhosis severity evaluated by numerical CTP score. Methods. A cross sectional study was conducted among 96 liver cirrhotic patients within age of 18-60 years old consecutively due to any causes who admitted to ambulatory unit of Hepatology and Internal Medicine Cipto Mangunkusumo General Hospital wards into intended sample. The study started in November 2013 until proper sample size was obtained. Echocardiography examination was performed by two operators. Interobserver validity was assesed with level of Kappa aggrement and mean difference. Data were extracted to determine prevalence, normality test, Spearman correlation test, and multivariate linear regression test using SPSS for Windows. Results. Left ventricular diastolic dysfunction proportion among liver cirrhotic patients according to ASE-EAE 2009 was 34,3% and 21,9% of normal diastolic function subgroup has left atrial volume index ≥34 mL/m2. Meanwhile, conventional approach resulted in 68,8% of diastolic dysfuncation. All diastolic parameter showed abnormalities on CTP B 8-10. Spearman’s r values of stage of diastolic dysfunction severity according to ASE-EAE 2009 with severity of numerical CTP score was 0,42 (p<0,001) and 0,54 based on conventional approach. Exclusion of diabetic patients and spironolactone treated patients resulted in r=0,51 (p <0,001) based on ASE-EAE 2009 and 0,63 (p<0,001) based on conventional approach.. Parameters of diastolic function that had relation with liver dysfunction severity in cirrhosis measured by numerical CTP were Ar-A (p=0,004), left atrial volume index (p=0,005), and laterale e’ (p=0,026). Conclusion. Severity of left ventricular diastolic dysfunction with severity of liver cirrhosis is positively correlated. Diastolic parameters relate with severity of liver cirrhosis are diastolic ventricular filling pressure with left ventricular chamber stiffness, left atrial remodelling and regurgitant of pulmonary venous flow velocity to oppose filling pressure. Early detection for diastolic dysfunction can be started on CTP B 8. Keywords: Child Turcotte Pugh Score, diastolic dysfunction, liver cirrhosis, liver dysfunction
Co-Authors A M. Rahman A. M. Rahman A.A. Ketut Agung Cahyawan W Abdulmuthalib Abdulmuthalib Agus Kosasih, Agus Aida Lydia Aina Nadila, Aina Ali Sakti, Ali Alida Roswita Harahap Amanda, Clara Riski Ardian Saputra, Ardian Arif Mansjoer Arif Sejati Aru W Sudoyo Ary H Reksodiputro, Ary H Asmarinah, A Astuti Giantini Auda Aziz, Auda Bambang Budi Siswanto Bambang Sutrisna Christopher Surya Suwita Cleopas Martin Rumende Cosphiadi Irawan Dasnan Ismail Dedi Afandi Dedi Wihanda, Dedi Dedy G Sudrajat, Dedy G Dharmeizar . Dharmeizar . Dharmeizar Dharmeizar Dicky Levenus Tahapary Diding Heri Prasetyo Djumhana Atmakusuma, Djumhana Djumhana Atmakusumah, Djumhana Dyah Purnamasari E. Mudjaddid A. Siswanto Deddy N.W.Achadiono Hamzah Shatri E. Mudjaddid E. Mudjaddid, E. Mudjaddid Edy Rizal Wahyudi Em Yunir, Em Endang Ratnaningsih Erlin Listiyaningsih Esthika Dewiasty, Esthika Faisal Yunus Faisal Yunus Faisal Yunus Ferry Sandra Franciscus D. Suyatna Frans Suyatna H. Prabowo Hananto Andriantoro Hardjanti Soelistijo Hari Utomo HB B. Trisnohadi Ika P Wijaya, Ika P Iman Firmansyah Iman Firmansyah Imelda Maria Loho, Imelda Maria Ina Susianti Timan Indrasari, Nuri Dyah Irsan Hasan Jeremia Immanuel Siregar, Jeremia Immanuel Jusuf Rachmat Jusuf Rachmat Karmel L. Tambunan Katarina Dewi Sartika Kevin Triangto Kuntjoro Harimurti Laurentius Lesmana Laurentius Lesmana Lia Gardenia Partakusuma Linda Lison, Linda Lukman H. Makmun Lukman Hakim Lyana Lyana, Lyana Marulam M Panggabean, Marulam M Marulam M. Panggabean Marulam M. Panggabean Merry Wintery, Merry Miftah Suryadipradja Mondrowinduro, Prionggo Muhadi Muhadi, Muhadi Muhammad Yamin Mulyadi M. Djer Murdani Abdullah Nikmah S Idris, Nikmah S Nurhay Abdurachman Nurhay Abdurahman Nury Nusdwinuringtyas Nury Nusdwinuringtyas Nury Nusdwinuringtyas Parlindungan Siregar Pradana Soewondo Pratama, Derin Anugrah Pudji Rahardjo Pudji Rahardjo Rachmat Hamonangan, Rachmat Rahajuningsih Dharma Rahmad Isnanta, Rahmad Ratih Tri Kusuma Dewi, Ratih Tri Kusuma Reksodiputro, Mirta Hediyati Renan Sukmawan Rianto Setiabudy Ronald Winardi Kartika S. Harun Saleha Sungkar Sally A. Nasution Sally Aman Nasution Santoso, Fidiaji Hiltono Saptawati Bardosono Saptawati Bardosono Sarwono Waspadji Sarwono Waspadji Sarwono Waspadji Satrio Sukmoko Shufrie Effendy Sidartawan Soegondo Simon Salim Siskawati Suparmin Siti B. Kresno Siti Setiati Slamet Suyono Soehardjono Soehardjono Sri Inggriani, Sri Sudrajat, Dedy G. Suzanna I Suzanna I Suzanna Immanuel Suzzana Immanuel Teguh Santoso Todung Silalahi Todung Silalahi Todung Silalahi Todung Silalahi Todung Silalahi Wahyu Dewabrata Widjajalaksmi Widjajalaksmi Windy Sahar